OxyContin 20 mg tablete s produljenim oslobađanjem
| Name | OxyContin 20 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-188823708 |
| Active Substance | oksikodonklorid |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 20 mg oksikodonklorida što odgovara 18 mg oksikodona |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Packaging [MA Number for Packaging] | 20 tableta u blisteru, u kutiji [HR-H-188823708-01] 30 tableta u blisteru, u kutiji [HR-H-188823708-02] 50 tableta u blisteru, u kutiji [HR-H-188823708-03] 60 tableta u blisteru, u kutiji [HR-H-188823708-04] 100 tableta u blisteru, u kutiji [HR-H-188823708-05] 100 tableta u blisteru, u kutiji (bolničko pakiranje) [HR-H-188823708-06] |
| Manufacturer | Fidelio Healthcare Limburg GmbH, Limburg, Njemačka Mundipharma DC B.V., Leusden, Nizozemska |
| Marketing Authorisation Holder | Mundipharma Gesellschaft m.b.H., Wiedner Gurtel 13, Turm 24, OG 15, Beč, Austrija |
| Marketing Authorisation Date | 13.09.2016 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/234 |
| Registration Number | 381-12-01/70-16-03 |
| Prescription | na recept |
| Type of prescription | poseban recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N02AA05 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
